Evidence map›Paper›PMID 40678955›Full record

ArticleThe Milbank quarterly2025

Maximizing the Public Health Benefits of Opioid Settlements: Policy Recommendations for Equity, Sustainability, and Impact.

Brandon D L Marshall, Kristen Pendergrass, Sara Whaley

Abstract read
In one paragraph

Article in The Milbank quarterly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brandon D L MarshallSchool of Public Health, Brown University.
Kristen PendergrassShatterproof.
Sara WhaleyBloomberg School of Public Health, Johns Hopkins University.

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI CURT G BECKWITH · 2018 to 2026
$23.4M
National Institute of General Medical Sciences P20-GM125507NIGMS NIH HHS P20 GM125507
6 · The paper itself

Abstract

Policy Points State and local governments are receiving over $50 billion in opioid settlement funds over 18 years to mitigate the harms from the opioid crisis. Lessons learned from the Tobacco Master Settlement of the 1990s can ensure that funds are administered according to best practices and are spent on evidence-based interventions. Recent efforts to track opioid settlement spending around the country shed light on encouraging trends such as overdose rate reductions, unmet challenges like reducing inequities, and areas in need of continued vigilance and improvement like transparency and evaluation.

Indexed as

Analgesics, OpioidHealth PolicyOpioid EpidemicOpioid-Related DisordersPublic HealthHumansUnited StatesAnalgesics, Opioidopioid‐related disordersopioid settlementoverdosepharmaceutical industry

Identifiers

PMID40678955
PMCPMC12673170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.